UK markets closed
  • NIKKEI 225

    26,170.30
    -841.03 (-3.11%)
     
  • HANG SENG

    23,807.00
    -482.90 (-1.99%)
     
  • CRUDE OIL

    87.42
    +0.81 (+0.94%)
     
  • GOLD FUTURES

    1,796.30
    +3.20 (+0.18%)
     
  • DOW

    34,160.78
    -7.31 (-0.02%)
     
  • BTC-GBP

    27,548.99
    -28.61 (-0.10%)
     
  • CMC Crypto 200

    813.93
    -5.57 (-0.68%)
     
  • ^IXIC

    13,352.78
    -189.34 (-1.40%)
     
  • ^FTAS

    4,230.83
    +38.13 (+0.91%)
     

Global Male Infertility Market to Reach $4.8 Billion by 2027

·25-min read

Abstract: - Global Male Infertility Market to Reach $4. 8 Billion by 2027. - Amid the COVID-19 crisis, the global market for Male Infertility estimated at US$3. 5 Billion in the year 2020, is projected to reach a revised size of US$4.

New York, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Male Infertility Industry" - https://www.reportlinker.com/p06032109/?utm_source=GNW
8 Billion by 2027, growing at a CAGR of 4.5% over the analysis period 2020-2027. DNA Fragmentation Technique, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oxidative Stress Analysis segment is readjusted to a revised 4.2% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $953 Million, While China is Forecast to Grow at 7.3% CAGR
- The Male Infertility market in the U.S. is estimated at US$953 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$990.9 Million by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
- Computer Assisted Semen Analysis Segment to Record 5.1% CAGR
- In the global Computer Assisted Semen Analysis segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$425.7 Million in the year 2020 will reach a projected size of US$592.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$643.6 Million by the year 2027, while Latin America will expand at a 5.5% CAGR through the analysis period.

- Select Competitors (Total 32 Featured) -

  • Andrology Solutions

  • Bayer AG

  • Cadila Pharmaceuticals Ltd.

  • Endo Pharmaceuticals Inc.

  • Halotech DNA

  • Intas Pharmaceuticals Ltd.

  • Merck KGaA

  • Sanofi

  • SCSA Diagnostics, Inc.

  • Vitrolife




Read the full report: https://www.reportlinker.com/p06032109/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Male Infertility
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Male Infertility by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Male Infertility by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for DNA Fragmentation
Technique by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for DNA Fragmentation Technique
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for DNA Fragmentation
Technique by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 7: World Current & Future Analysis for Oxidative Stress
Analysis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Oxidative Stress Analysis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Oxidative Stress
Analysis by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 10: World Current & Future Analysis for Computer Assisted
Semen Analysis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Computer Assisted Semen
Analysis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Computer Assisted Semen
Analysis by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 13: World Current & Future Analysis for Sperm
Agglutination by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Sperm Agglutination by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Sperm Agglutination by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Microscopic
Examination by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Microscopic Examination by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Microscopic Examination
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Sperm Penetration
Assay by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Sperm Penetration Assay by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Sperm Penetration Assay
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other Test Types
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Other Test Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other Test Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Assisted
Reproductive Technology & Varicocele Surgery by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Assisted Reproductive
Technology & Varicocele Surgery by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Assisted Reproductive
Technology & Varicocele Surgery by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Medication by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Medication by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 30: World 15-Year Perspective for Medication by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Male Infertility by
Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Male Infertility by Test Type -
DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Male Infertility by Test
Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Male Infertility by Treatment -
Assisted Reproductive Technology & Varicocele Surgery and
Medication Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

JAPAN
Table 43: Japan Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 46: Japan Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

CHINA
Table 49: China Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 50: China Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 52: China Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 53: China Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 54: China 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

EUROPE
Table 55: Europe Current & Future Analysis for Male Infertility
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 56: Europe Historic Review for Male Infertility by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Male Infertility by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 59: Europe Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 61: Europe Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 62: Europe Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: Europe 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

FRANCE
Table 64: France Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 65: France Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 66: France 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 67: France Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 68: France Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 69: France 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

GERMANY
Table 70: Germany Current & Future Analysis for Male
Infertility by Test Type - DNA Fragmentation Technique,
Oxidative Stress Analysis, Computer Assisted Semen Analysis,
Sperm Agglutination, Microscopic Examination, Sperm Penetration
Assay and Other Test Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 71: Germany Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 72: Germany 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 73: Germany Current & Future Analysis for Male
Infertility by Treatment - Assisted Reproductive Technology &
Varicocele Surgery and Medication - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 74: Germany Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: Germany 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

ITALY
Table 76: Italy Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 77: Italy Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 78: Italy 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 79: Italy Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 80: Italy Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 81: Italy 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 82: UK Current & Future Analysis for Male Infertility by
Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 83: UK Historic Review for Male Infertility by Test Type -
DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 84: UK 15-Year Perspective for Male Infertility by Test
Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 85: UK Current & Future Analysis for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 86: UK Historic Review for Male Infertility by Treatment -
Assisted Reproductive Technology & Varicocele Surgery and
Medication Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 87: UK 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

SPAIN
Table 88: Spain Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: Spain Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 90: Spain 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 91: Spain Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 92: Spain Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 93: Spain 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

RUSSIA
Table 94: Russia Current & Future Analysis for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 95: Russia Historic Review for Male Infertility by Test
Type - DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 96: Russia 15-Year Perspective for Male Infertility by
Test Type - Percentage Breakdown of Value Sales for DNA
Fragmentation Technique, Oxidative Stress Analysis, Computer
Assisted Semen Analysis, Sperm Agglutination, Microscopic
Examination, Sperm Penetration Assay and Other Test Types for
the Years 2012, 2020 & 2027

Table 97: Russia Current & Future Analysis for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: Russia Historic Review for Male Infertility by
Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 99: Russia 15-Year Perspective for Male Infertility by
Treatment - Percentage Breakdown of Value Sales for Assisted
Reproductive Technology & Varicocele Surgery and Medication for
the Years 2012, 2020 & 2027

REST OF EUROPE
Table 100: Rest of Europe Current & Future Analysis for Male
Infertility by Test Type - DNA Fragmentation Technique,
Oxidative Stress Analysis, Computer Assisted Semen Analysis,
Sperm Agglutination, Microscopic Examination, Sperm Penetration
Assay and Other Test Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 101: Rest of Europe Historic Review for Male Infertility
by Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Rest of Europe 15-Year Perspective for Male
Infertility by Test Type - Percentage Breakdown of Value Sales
for DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,
Microscopic Examination, Sperm Penetration Assay and Other Test
Types for the Years 2012, 2020 & 2027

Table 103: Rest of Europe Current & Future Analysis for Male
Infertility by Treatment - Assisted Reproductive Technology &
Varicocele Surgery and Medication - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 104: Rest of Europe Historic Review for Male Infertility
by Treatment - Assisted Reproductive Technology & Varicocele
Surgery and Medication Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 105: Rest of Europe 15-Year Perspective for Male
Infertility by Treatment - Percentage Breakdown of Value Sales
for Assisted Reproductive Technology & Varicocele Surgery and
Medication for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 106: Asia-Pacific Current & Future Analysis for Male
Infertility by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 107: Asia-Pacific Historic Review for Male Infertility by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Male
Infertility by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 109: Asia-Pacific Current & Future Analysis for Male
Infertility by Test Type - DNA Fragmentation Technique,
Oxidative Stress Analysis, Computer Assisted Semen Analysis,
Sperm Agglutination, Microscopic Examination, Sperm Penetration
Assay and Other Test Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: Asia-Pacific Historic Review for Male Infertility by
Test Type - DNA Fragmentation Technique, Oxidative Stress
Analysis, Computer Assisted Semen Analysis, Sperm
Agglutination, Microscopic Examination, Sperm Penetration Assay
and Other Test Types Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 111: Asia-Pacific 15-Year Perspective for Male
Infertility by Test Type - Percentage Breakdown of Value Sales
for DNA Fragmentation Technique, Oxidative Stress Analysis,
Computer Assisted Semen Analysis, Sperm Agglutination,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032109/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting